Inside Insights

Top 25 U.S. law firms named by brand

By Julie Beck | February 3, 2012

On Wednesday, global legal market research specialist Acritas released its first-ever U.S. Law Firm Brand Index report, which ranks the nation’s top 25 firms by the strength of their brand
BofA wins dismissal from Allstate Countrywide suit

By Alex Vorro | February 3, 2012

Perhaps the New Year has brought a fresh set of luck for the beleaguered bank. After basically taking it on the chin again and again in 2011, Bank of America Corp. (BofA) caught a break in its battle with Allstate Insurance Co.
Days before Super Bowl, ICE seizes websites that illegally stream sporting events

By Ashley Post | February 3, 2012

He may be a National Football League (NFL) quarterback on his way to the Super Bowl this Sunday, but he also has dabbled in crime.
Legal jobs market bounces back slightly in January

By Alex Vorro | February 3, 2012

On the heels of the U.S. economy adding 243,000 jobs in January, and the unemployment rate dropping to 8.3 percent (the lowest rate since February 2009), it stands to reason that the legal job market also benefitted from all the gains, right?
5 notable GCs in the news

By Julie Beck | February 3, 2012

Tracking some of the most-significant quotes from general counsel in the mainstream media
Former unpaid intern sues Hearst Corp., seeks class action

By Julie Beck | February 2, 2012

The unpaid intern rebellion is picking up steam.
Macy’s seeks injunction in spat with Martha Stewart

By Alex Vorro | February 2, 2012

The bad blood between Macy’s Inc. and Martha Stewart Living Omnimedia Inc. continues to boil.
12 law schools sued over misleading jobs data

By Ashley Post | February 2, 2012

Yesterday, a group of recent law school graduates banded together to sue their alma maters.
Honda Civic Hybrid owner wins $9,867 in small claims court

By Ashley Post | February 2, 2012

A Civic owner who refused to join a class action settlement against Honda Motor Corp. is reaping the rewards of her decision.
FDA employees accuse agency of spying on them

By Julie Beck | February 1, 2012

Three years ago, nine U.S. Food and Drug Administration (FDA) employees sent a letter to President Obama’s transition team, alleging that the FDA had been improperly approving medical devices, including one that screens for breast cancer.